Drug intelligence / Profile preview

human bone marrow mesenchymal stem cell

Development stage
Phase 2
Lead developer
MilliporeSigma
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intraarticular, Intramuscular, Intrathecal, Local Injection, Intraosseous, Surgical Implantation
01

Overview

Human bone marrow mesenchymal stem cells (BM-MSCs) are multipotent adult stromal cells isolated from the bone marrow. They possess the ability to self-renew and differentiate into multiple lineages including osteoblasts (bone cells), chondrocytes (cartilage cells), adipocytes (fat cells), and in some cases myocytes or neural-like cells[1][2][3][4]. BM-MSCs play a key role in tissue repair by secreting bioactive factors that modulate inflammation and promote regeneration. They also exhibit immunomodulatory properties by suppressing immune responses and reducing inflammation[2][5]. These characteristics make them a central focus of regenerative medicine research for conditions such as autoimmune diseases, graft versus host disease, Crohn's disease, multiple sclerosis, systemic lupus erythematosus, systemic sclerosis, sepsis-related organ injury and various degenerative or traumatic tissue injuries[2][5]. BM-MSCs are typically expanded in vitro for clinical use; they are characterized by adherence to plastic surfaces under standard culture conditions and expression of specific surface markers such as CD29, CD44, CD73, CD90, CD105 while lacking hematopoietic markers like CD14/CD34/CD45[7].

Other names
human bone marrow mesenchymal stromal cellhuman MSCBM-MSCbone marrow-derived mesenchymal stem cell

Beyond the preview

Go deeper on human bone marrow mesenchymal stem cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human bone marrow mesenchymal stem cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call